CyBio AG
- ISIN DE0005412308
- Country Germany
Company profile
Cybio AG, with headquarters in Jena/Germany and sales subsidiaries in Europe and the USA is a worldwide acting life science company. With more than 15 years of experience CyBio develops, produces and sells technology platforms for drug discovery. The portfolio covers a broad range of excellent solutions for pharmaceutical and agrochemical research: liquid handling, incubation, imaging reader, software and system integration to achieve fully automated screening technologies. CyBio is a global market leader in the field of simultaneous pipetting technology